SEARCH

SEARCH BY CITATION

References

  • Alexanian, R., Bonnet, D., Gehan, E., Haut, A., Hewlett, J., Lane, M., Monto, R., Wilson, H. (1972) Combination chemotherapy for multiple myeloma. Cancer, 30, 382389.
  • Arceci, R.J. (1993) Clinical significance of P-glycoprotein in multidrug resistance malignancies. Blood, 81, 22152222.
  • Attal, M., Harousseau, J.L., Stoppa, A.M., Sotto, J.J., Fuzibet, J.G., Rossi, J.F., Casassus, P., Maisonneuve, H., Facon, T., Ifrah, N., Payen, C., Bataille, R. (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. New England Journal of Medicine, 335, 9197.
  • Buyse, M.E.., Staquet, M.J., Sylvester, R.J. (1992) Cancer Clinical Trials; Methods and Practice. Oxford Medical Publications, Oxford.
  • Dalton, W.S., Grogan, T.M., Meltzer, P.S., Scheper, R.J., Durie, B.G., Taylor, C.W., Miller, T.P., Salmon, S.E. (1989) Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma. detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. Journal of Clinical Oncology, 4, 415424.
  • Dalton, W.S., Crowley, J.J., Salmon, S.S., Grogan, T.M., Laufman, L.R., Weiss, G.R., Bonnet, J.D. (1995) A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study. Cancer, 75, 815820.
  • Den Ouden, D., Van Den Heuvel, M., Schoester, M., Van Rens, G., Sonneveld, P. (1996) In vitro effect of GF120918, a novel reversal agent of multidrug resistance, on acute leukemia and multiple myeloma cells. Leukemia, 10, 19301936.
  • Durie, G.B.M. & Dalton, W.S. (1988) Reversal of drug resistance in multiple myeloma with verapamil. British Journal of Haematology, 68, 203205.
  • Epstein, J., Xiao, H.Q., Oba, B.K. (1989) P-glycoprotein expression in plasma-cell myeloma is associated with resistance to VAD. Blood, 74, 913918.
  • Fojo, A.T., Ueda, K., Slamon, D.J., Poplack, D.G., Gottesman, M.M., Pastan, I. (1987) Expression of a multi-drug resistance gene in human tumors and tissues. Proceedings of the National Academy of Sciences USA, 84, 265269.
  • Futscher, B.W., Foley, N.E., Gleason-Guzman, M.C., Meltzer, P.S., Sullivan, D.M., Dalton, W.S. (1996) Verapamil suppresses the emergence of P-glycoprotein-mediated multi-drug resistance. International Journal of Cancer, 66, 520525.DOI: 10.1002/(sici)1097-0215(19960516)66:4<520::aid-ijc16>3.0.co;2-b
  • Gardner, M.J. & Altman, D.G. (1989) Statistics with Confidence – Confidence Intervals and Statistical Guidelines. British Medical Journal, London.
  • Gieseler, F. & Nussler, V. (1998) Cellular resistance mechanisms with impact on the therapy of multiple myeloma. Leukemia, 12, 10091012.
  • Gregory, W.M., Richards, M.A., Malpas, J.S. (1992) Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials. Journal of Clinical Oncology, 10, 334342.
  • Grogan, T., Dalton, W., Rybski, J., Spier, C., Meltzer, P., Richter, L., Gleason, M., Pindur, J., Cline, A., Scheper, R. (1990) Optimization of immunocytochemical P-glycoprotein assessment in multidrug-resistant plasma cell myeloma using three antibodies. Laboratory Investigations, 63, 815824.
  • Grogan, T.M., Spier, C.M., Salmon, S.E., Matzner, M., Rybski, J., Weinstein, R.S., Scheper, R.J., Dalton, W.S. (1993) P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy. Blood, 81, 490495.
  • Herwijer, H., Sonneveld, P., Baas, F., Nooter, K. (1990) Expression of mdr1 and mdr2 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine. Journal of the National Cancer Institute, 82, 11331140.
  • Pilarski, L.M., Yatscoff, R.W., Murphy, G.F., Belch, A.R. (1998) Drug resistance in multiple myeloma: cyclosporin A analogues and their metabolites as potential chemosensitizers. Leukemia, 12, 505509.
  • Raaijmakers, H.G., Izquierdo, M.A., Lokhorst, H.M., De Leeuw, C., Belien, J.A., Bloem, A.C., Dekker, A.W., Scheper, R.J., Sonneveld, P (1998) Lung-resistance-related protein expression is a negative predictive factor for response to conventional low but not to intensified dose alkylating chemotherapy in multiple myeloma. Blood, 91, 10291036.
  • Salmon, S.E., Dalton, W.S., Grogan, T.M., Plezia, P., Lehnert, M., Roe, D.J., Miller, T.P. (1991) Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer. Blood, 78, 4450.
  • Samson, D., Newland, A., Kearney, J., Joyner, M., Mitchell, T., Barrett, A.J., Gaminara, E., Van De Pette, J., McCarthy, D., Aston, L., Hamon, M., Evans, M. (1989) Infusions of vincristine and doxorubicin with oral dexamethasone as first-line therapy for multiple myeloma,. Lancet, ii, 882885.
  • Segeren, C.M., Sonneveld, P., Van Der Holt, B., Baars, J.W., Biesma, D.H., Cornelissen, J.J., Croockewit, A.J., Dekker, A.W., Fibbe, W.E., Löwenberg, B., Van Marwijk Kooy, B.M., Van Oers, M.H.J., Richel, D.J., Schouten, H.C., Vellenga, E., Verhoef, G.E.G., Wijermans, P.W., Wittebol, S., Lokhorst, H.M. (1999) Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid fusion for first-line treatment in untreated multiple myeloma. British Journal of Haematology, 105, 127130.
  • Solary, E., Bidan, J.M., Calvo, F., Chauffert, B., Caillot, D., Mugneret, F., Gauville, C., Tsuruo, T., Carli, P.M., Guy, H. (1991) P-glycoprotein expression and in vitro reversion of doxorubicin resistance by verapamil in clinical specimens from acute leukaemia and myeloma. Leukemia, 5, 592597.
  • Sonneveld, P. (1999) Drug resistance in multiple myeloma. Pathology Biology (Paris), 47, 182187.
  • Sonneveld, P., Durie, B.G.M., Lokhorst, H.M., Marie, J.P., Solbu, G., Suciu, S., Zittoren, R., Löwenberg, B., Nooter, K. (1992) Modulation of multidrug resistance by cyclosporin. The Lancet, 340, 255259.
  • Sonneveld, P., Schoester, M., De Leeuw, K. (1994) Clinical modulation of multidrug resistance in multiple myeloma. Journal of Clinical Oncology, 12, 15841591.
  • Sonneveld, P., Marie, J.P., Huisman, C., Vekhoff, A., Schoester, M., Faussat, A.M., Van Kapel, J., Groenewegen, A., Charnick, S., Zittoan, R., Löwenberg, B. (1996) Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma. A phase I study. Leukemia, 10, 17411750.
  • Tsuruo, T., Iida, H., Tsukagoshi, S., Sakurai, Y.T. (1983) Potentiation of vincristine and adriamycin effects in human hematopoietic tumor cells lines by calcium cannel antagonists and calmodulin inhibitors. Cancer Research, 43, 22672271.